Table of Contents
| Rare myeloid sarcoma/acute myeloid leukemia with adrenal mass after allogeneic mobilization peripheral blood stem cell transplantation | PDF HTML |
| Ya-Fei Wang, Qian Li, Wen-Gui Xu, Jian-Yu Xiao, Qing-Song Pang, Qing Yang, Yi-Zuo Zhang | 232-235 |
Perspective
| Global progress against cancer—challenges and opportunities | PDF HTML |
| Frédéric Biemar, Margaret Foti | 183-186 |
Review
| Asian trends in primary androgen depletion therapy on prostate cancer | PDF HTML |
| Hideyuki Akaza | 187-191 |
| Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks | PDF HTML |
| German G. Gomez, Jill Wykosky, Ciro Zanca, Frank B. Furnari, Webster K. Cavenee | 192-205 |
| Why bortezomib cannot go with ‘green’? | PDF HTML |
| Li Jia | 206-213 |
| Translational genomics in cancer research: converting profiles into personalized cancer medicine | PDF HTML |
| Lalit Patel, Brittany Parker, Da Yang, Wei Zhang | 214-220 |
Original Article
| Effects of HLEC on the secreted proteins of epithelial ovarian cancer cells prone to metastasize to lymph nodes | PDF HTML |
| Xin-Ying Zhang, Fu-Qiang Yin, Li Liu, Ting Gao, He-Yun Ruan, Xiao Guan, Ying-Xin Lu, Dan-Rong Li | 221-226 |
| Analysis of 30 patients with persistent or recurrent squamous cell carcinoma of the cervix within one year after concurrent chemoradiotherapy | PDF HTML |
| Shi-Ping Liu, Jia-Xin Yang, Dong-Yan Cao, Keng Shen | 227-231 |
OUR FRIENDS
